All Stories

  1. Previous use of Statins and Atrial Electrical Remodeling in Patients with Cryptogenic Stroke
  2. Postoperative atrial fibrillation and ischemic stroke: The role of homocysteine
  3. How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion
  4. Neuroimaging of Takayasu Arteritis in a Patient with Ulcerative Rectocolitis
  5. To the Editor— Anticoagulation in atrial fibrillation after intracranial hemorrhage: Could the hemorrhage location influence the outcome?
  6. Letter by Acampa et al Regarding Article, “Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection”
  7. Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis
  8. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
  9. To the Editor— Carnitine and ventricular repolarization: a complex link?
  10. Ischemic Stroke after Heart Transplantation
  11. Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes
  12. Double ophthalmic arteries arising from the internal carotid artery: a case report of a hidden second ophthalmic artery
  13. Echocardiographic evaluation in Rett children with cardiac dysautonomia
  14. P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
  15. Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation
  16. Response: Aortic Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage: Role of Antihypertensive Drugs and Statins
  17. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation
  18. Time Course of Corticospinal Excitability and Autonomic Function Interplay during and Following Monopolar tDCS
  19. Thrombolytic Treatment of Cardiac Myxoma-Induced Ischemic Stroke: A Review
  20. Arterial Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage
  21. Stroke warning syndrome: 18 new cases
  22. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis
  23. Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis
  24. Systemic thrombolysis for stroke in pregnancy
  25. Safety of Intravenous Thrombolysis in Ischemic Stroke Caused by Left Atrial Myxoma
  26. Anti-Ro/SSA-associated corrected QT interval prolongation in adults: The role of antibody level and specificity
  27. Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting
  28. Homocysteine and P wave dispersion in patients with heart transplantation
  29. Arrhythmogenic effects of anti-Ro/SSA antibodies on the adult heart: More than expected?
  30. Autonomic Nervous System Alterations in Rett Syndrome
  31. Cardiac dysautonomia and arterial distensibility in essential hypertensives
  32. Sympathetic overactivity and plasma leptin levels in Rett syndrome
  33. Delineation of the phenotype associated with 7q36.1q36.2 deletion: Long QT syndrome, renal hypoplasia and mental retardation
  34. Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications
  35. Pharmacogenetics of Statins Therapy
  36. Comparison of Frequency of Complex Ventricular Arrhythmias in Patients With Positive Versus Negative Anti-Ro/SSA and Connective Tissue Disease
  37. Connective tissue diseases and cardiac rhythm disorders: An overview
  38. Cardiac disease and Rett syndrome
  39. Effects of Acetyl-L-carnitine on Cardiac Dysautonomia in Rett Syndrome: Prevention of Sudden Death?
  40. Reply
  41. Autonomic Dysfunction in Mental Retardation and Spastic Paraparesis With MECP2 Mutation
  42. Sudden Death and Cardiac Arrhythmias in Rett Syndrome
  43. Nerve Growth Factor Plasma Levels and Ventricular Repolarization in Rett Syndrome
  44. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases
  45. Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A stress echocardiographic study
  46. Progressive Cardiac Dysautonomia Observed in Patients Affected by Classic Rett Syndrome and Not in the Preserved Speech Variant
  47. Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer
  48. Progressive Cardiac Dysautonomia Observed in Patients Affected by Classic Rett Syndrome and Not in the Preserved Speech Variant
  49. Reduced Heart Rate Variability in Patients Affected with Rett Syndrome. A Possible Explanation for Sudden Death